Evaluation of clinical benefits and economic value of weight loss in a Swedish population using a simulation model
Authors' conclusion
Annual treatment costs of ORCs in Sweden will double over 10 years, and weight loss would be associated with significant savings because of the reductions in the incidence of ORCs. Therefore, there is an urgent need to effectively treat obesity to prevent morbidity.
Study context
- Population
- 2023 Swedish population with obesity aged 20 to 60 years; random cohort of 10,000 individuals simulatedmodelled cohort 10,000
- Participants
- 887,272 participants
- Comparison
- Weight-loss scenarios vs stable weight
- Outcome
- Incidence of 10 obesity-related complications (ORCs) and treatment costs
- Follow-up
- 10 years
Methodological detailsvalue of weight-loss simulation model, 10-year horizon
- Value of weight-loss simulation model
- 10-year horizon
Main finding
As reported in the abstract
Annual savings from prevented ORCs per 10,000 individuals · by 2033
Annual savings, 5% weight loss
9.0 million SEK/€0.8 million
Annual savings, 20% weight loss
30.0 million SEK/€2.6 million
Further findings
Prevalence of ORCs
- Hypertension
- 24.1%
- Asthma
- 20.9%
- Dyslipidemia
- 18.3%
- T2D
- 10.6%
Original publication
Evaluation of clinical benefits and economic value of weight loss in a Swedish population using a simulation model. Obesity (Silver Spring). Published 12 March 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →